Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Mount Sinai Selects Exemplar LIMS for Genomics Core Facility

Published: Tuesday, May 07, 2013
Last Updated: Tuesday, May 07, 2013
Bookmark and Share
Exemplar LIMS utilized for Mount Sinai CLIA-certified Genomics Core Facility employing diverse NGS platforms

Exemplar LIMS™ has been selected as the lab management solution for the Genomics Core Facility at The Mount Sinai Medical Center in New York.  Sapio's LIMS system will track multiple next-generation sequencing (NGS) platform workflows from request through secondary analysis.

The Mount Sinai Genomics Core Facility is a CLIA-certified laboratory, and Exemplar LIMS is used to perform the detailed tracking required for NGS clinical sample processing.  The Exemplar LIMS system enables the Mount Sinai user community to submit samples online and track the sequencing process.  Also, Exemplar LIMS offers automatic initiation of primary analysis at the end of the sequencing process and provides frequent progress updates to users.  Exemplar also generates billing information that is passed onto the Mount Sinai financial system.

"Mount Sinai is a world leader in the genomics domain at the forefront of NGS research, with one of the few labs certified for processing clinical NGS samples in the US," said Kevin Cramer, VP at Sapio Sciences. "We look forward to working with the Mount Sinai team to streamline their lab operations while tracking the complete NGS pipeline."

"We selected Exemplar LIMS as it is modular in structure and configurable to expand and adapt with rapidly changing NGS and other genomic technologies," said Milind Mahajan, Ph.D., Director of the Genomics Core Facility at Mount Sinai. "Exemplar supports our CLIA sequencing and cutting-edge biological research to develop multi-scale models of disease."

Mount Sinai will also utilize Exemplar's Materials Management capability for reagent usage tracking.  Sapio's LIMS software will be deployed on Apple iPads™ using Exemplar LIMS for Tablets solution.  This enables lab technicians to take the LIMS with them as they move around the laboratory improving LIMS usability and lab technician efficiency.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New York Genome Institute Selects Exemplar LIMS to Manage Next Gen Sequencing Labs
Sapio Solutions' Exemplar LIMS selected by NY Genome Center's laboratory operations.
Sunday, March 03, 2013
New York Genome Institute Selects Exemplar LIMS to Manage Next Gen Sequencing Labs
Sapio Sciences' Exemplar LIMS to be utilized for NYGC High Throughput Next Gen Sequencing Labs
Wednesday, February 13, 2013
Sapio Sciences Announces Exemplar LIMS for Tablet Computers
Lab Technicians can now use Exemplar LIMS Untethered.
Wednesday, November 14, 2012
Scientific News
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Bioreactors Ready for the Big Time
Bioreactors are passive filtration systems that can reduce nitrate losses from farm fields.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Finding Factors That Protect Against Flu
A clinical trial examining the body’s response to seasonal flu suggests new approaches for evaluating the effectiveness of seasonal flu vaccines.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!